EYE DISEASE BIOMARKER
    21.
    发明申请

    公开(公告)号:US20200270686A1

    公开(公告)日:2020-08-27

    申请号:US16089114

    申请日:2017-03-28

    Abstract: The principal purpose of the present invention is to provide a biomarker that makes it possible to conveniently and accurately assess corneal or conjunctival disease, and can use lacrimal fluid as the sample thereof. In addition, a main object of the present invention is to provide a biomarker that makes it possible to conveniently and accurately evaluate central serous chorioretinopathy. The present invention also provides a diagnostic kit containing a reagent capable of detecting the biomarker, and a diagnosis method that uses the biomarker. It is possible to use mitochondrial DNA included in lacrimal fluid as the biomarker for corneal or conjunctival disease.

    METHOD FOR DETERMINING ANATOMICAL SITES OF BODY SURFACE TISSUE

    公开(公告)号:US20190390274A1

    公开(公告)日:2019-12-26

    申请号:US16480938

    申请日:2018-01-26

    Abstract: An object of the present invention is to provide a method for determining anatomical sites of a body surface tissue. Provided is a method for determining an anatomical site of origin of a body surface tissue specimen, the method comprising the steps of:(A) selecting at least 8 kinds of genes from the group consisting of a Hox gene family and a Pax6 gene; (B) measuring the expression levels of the genes selected in the above (A) in the body surface tissue specimen; and (C) determining the anatomical site of origin of the body surface tissue specimen based on the expression levels or a combination of the expression levels measured in the above (B).

Patent Agency Ranking